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Edited by Beat ImhofAbstract Epigallocatechin-3-gallate (EGCG), a major form of
tea catechin, has anti-allergic properties. To elucidate the anti-
allergic mechanisms of EGCG, we investigated its regulation
of matrix metalloproteinase (MMP-9) expression in toluene diis-
ocyanate (TDI)-inhalation lung tissues as well as TNF-a and
Th2 cytokine (IL-5) production in BAL ﬂuid. Compared with
untreated asthmatic mice those administrated with EGCG had
signiﬁcantly reduced asthmatic reaction. Also, increased reactive
oxygen species (ROS) generation by TDI inhalation was dimin-
ished by administration of EGCG in BAL ﬂuid. These results
suggest that EGCG regulates inﬂammatory cell migration possi-
bly by suppressing MMP-9 production and ROS generation, and
indicate that EGCG may be useful as an adjuvant therapy for
bronchial asthma.
 2006 Federation of European Biochemical Societies. Published
by Elsevier B.V. All rights reserved.
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Asthma is a chronic inﬂammatory lung disease characterized
by airway hyper-responsiveness (AHR) to allergens, airway
edema, and increased mucus secretion. A propensity to allergic
responses, atopy, are associated with the development of asth-
ma [1]. Oxidative stress is caused by a large variety of free rad-
icals known as reactive oxygen species (ROS). Much evidence
has suggested that ROS plays an essential role in the pathogen-
esis of airway inﬂammation [2–4]. The inﬂammatory cells re-
cruited to the asthmatic airways are able to produce ROS.
Evidence of an increase in oxidative stress in asthma is alsoAbbreviations: EGCG, epigallocatechin-3-gallate; TDI, toluene diiso-
cyanate; ROS, reactive oxygen species; MMP-9, matrix metallopro-
teinase; AHR, airway hyper-responsiveness
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capacity in asthmatic patients [5]. For these reasons, antioxi-
dant treatment of asthma has long been a promising subject
of therapeutic strategy.
Toluene diisocyanate (TDI)-induced asthma is characterized
by AHR and inﬂammation of the airway [6]. This inﬂamma-
tion is associated with the inﬁltration of eosinophils, neutro-
phils, and lymphocytes into the bronchial lumen and lung
tissues [6,7]. These cellular inﬁltrates release various chemical
mediators, which can cause AHR [8–10]. Recruitment of these
inﬂammatory cells from the blood to the site of inﬂammation
is regarded as a critical event in the development and prolon-
gation of airway inﬂammation. Inﬂammatory cells have to
cross the basement membrane and move through connective
tissue until they ﬁnally reach inﬂammatory sites, and require
the involvement of adhesion molecules, cytokines, chemokine
and enzymes including matrix metalloproteinases (MMPs) in
this journey. MMPs are a family of zinc-dependent and cal-
cium-dependent endopeptidases capable of proteolytically
degrading many of the components of the extracellular matrix
[11]. MMPs are produced not only by structural cells [12,13],
but also by inﬂammatory cells [14–17]. They are secreted as la-
tent forms followed by proteolytic processing to active forms
[11]. Of the MMP family, MMP-2 (gelatinase A, 72-kDa gela-
tinase) and MMP-9 (gelatinase B, 92-kDa gelatinase) are
MMPs that share similar domain structures and in vitro ma-
trix substrate speciﬁcities [18], and appear to induce the migra-
tion of eosinophils, lymphocytes, neutrophils, and dendritic
cells [19,20].
Tea (Camellia sinensis L.) is one of the most widely con-
sumed beverages in the world, and is known to contain various
beneﬁcial constituents such as epigallocatechin-3-gallate
(EGCG). It has been demonstrated that EGCG exhibits vari-
ous biological and pharmacological properties that have been
reported to act in several antioxidative [21,22] and anticarcino-
genic ways [23,24]. EGCG, which is the major catechin in tea
leaves, apparently has the most essential role in these actions.
Interestingly, EGCG and the O-methylated derivative of
EGCG (EGCG 0 03Me) have been shown to inhibit type I al-
lergy [25]. In addition, many inﬂammatory proteins expressed
in asthmatic airways are regulated by NF-jB, including the
TNF-a [26,27], all of which are closely involved in the patho-
genesis of asthma. Recently, we have reported that EGCGblished by Elsevier B.V. All rights reserved.
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ration of murine dendritic cells through inhibition of mito-
gen-activated protein kinases and NF-jB [28]. It has also
been reported that EGCG has an inhibitory eﬀect on the gela-
tinolytic activity of MMP-2 [29]. In the present study, we
investigated whether EGCG has an inhibitory eﬀect against
TDI-induced asthma in mice.2. Materials and methods
2.1. Animals and experimental protocols
Female BALB/c mice, 6–8 weeks of age and free of murine speciﬁc
pathogens, were obtained from the Orient (Seoul, Korea). All of the
experimental animals used in this study were under a protocol approved
by the Institutional Animal Care and Use Committee of the Pusan Na-
tional University College of Medicine. Mice were sensitized twice by 2
courses of intranasal administration of 3% TDI dissolved in ethyl ace-
tate/olive oil (1:4) once per day for 5 consecutive days with a 3-week
interval, as previously described [24,25]. Seven days later, the mice were
challenged through the airways with 1% TDI dissolved in ethyl acetate/
olive oil (1:4) by ultrasonic nebulization (NE-U12, Omron, Tokyo, Ja-
pan) (Fig. 1). To establish a control, mice were sensitized and chal-
lenged with the use of the same protocol but only with the solvent,
ethyl acetate/olive oil (1:4). Bronchoalveolar lavage (BAL) was per-
formed at 2 days after the TDI-challenge. After euthanasia with sodium
pentobarbital (100 mg/kg body weight), pre-warmed 0.9% NaCl solu-
tion (500 ll) was slowly infused into the lungs and withdrawn. The total
cell numbers were counted with a hemacytometer. Smears of BAL cells
prepared with Cytospin II (Shandon, Runcorn, UK) were stained with
Diﬀ-Quik solution (Dade Diagnostics of P.R. Inc., Aguada, PR) for
diﬀerential cell counting. Two independent, blinded investigators
counted the cells, using a microscope. Approximately 200 cells were
counted in each of four diﬀerent random locations.
2.2. Administration of EGCG
Mice were fed ad libitum 0.3% EGCG (TEAVIGO, Roche Vita-
mins Ltd., Basel) in their drinking water with a light-protected bottle
from last sensitization to 2 days after ﬁrst challenge.
2.3. Measurement of intracellular ROS
ROS were measured by a method described previously with modiﬁ-
cation [30–32]. BAL ﬂuids were washed with phosphate-buﬀered saline
(PBS). To measure intracellular ROS, cells were incubated for 10 min
at room temperature with PBS containing 3.3 lM 2 0,7 0-dichloroﬂuo-
rescein diacetate (DCFDA) (Molecular Probes, Eugene, OR), to label
intracellular ROS. The cells were then immediately observed ﬂuores-
cence-activated cell sorting (FACS) analysis (Beckton Dickinson,
San Jose, CA).
2.4. Cytokine measurements
Levels of TNF-a and IL-5 (Endogen Inc., Woburn, MA) in BAL ﬂu-
ids were measured with a speciﬁc mouse (m) TNF-a and IL-5 ELISA
kit. The detection limit of the TNF-a and IL-5 assay were 5 pg/ml,
and the assay is said by the manufacturer to be speciﬁc for TNF-a
and IL-5.Fig. 1. Schematic diagram of the experimental protocol. Mice were sensitized
week interval. Seven days later, the mice were challenged through the airway
To establish a control, mice were sensitized and challenged with the use of th
Mice were fed ad libitum 0.3% EGCG in their drinking water with a light-p2.5. Zymography
The gelatinolytic activity of MMP-9 was measured by gelatin
zymography, as described previously [33,34]. Brieﬂy, a total of 10 ll
of BAL ﬂuid was subjected to electrophoresis in 10% polyacrylamide
gel containing gelatin (1 mg/ml). The gel was washed in 2.5% Triton
X-100 to permit renaturation of gelatinases, and stained with Coomas-
sie blue after overnight incubation. Destaining visualized clear zones of
lysis against a blue background, indicating gelatinase activity [35].
2.6. Western blot analysis
The lung tissues were homogenized, washed with PBS, and incu-
bated in lysis buﬀer in addition to a protease inhibitor cocktail (Sigma,
St. Louis, MO) to obtain extracts of lung proteins. A Western blot
analysis was performed as described previously [18]. The samples were
loaded to 10% SDS–PAGE gels and were separated at 120 V for
90 min. The blots were incubated with an anti-MMP-9 antibody di-
luted at a ratio of 1:800 overnight at 4 C. The membranes were
stripped and reblotted with anti-actin antibody (Sigma) to verify the
equal loading of protein in each lane.
2.7. RNA isolation and RT-PCR
The total RNA from lung tissues was isolated with the use of a rapid
extraction method (TRI-Reagent), as previously described [16]. The to-
tal RNA was reverse-transcribed to cDNA in a buﬀer. The single-
strand cDNAs were used for the PCR ampliﬁcation of MMP-9,
ICAM-1, VCAM-1, or GADPH. The PCR ampliﬁcation was per-
formed by mixing 3 ll of RT reaction with 47 ll of buﬀer containing
2.5 U of Taq DNA polymerase (Promega, Madison, WI) and
30 pmol/L of speciﬁc primer pairs for mouse cDNAs of MMP-9,
ICAM-1, VCAM-1, or GAPDH, according to published mouse gene
sequences. All of the signals were visualized and analyzed by densito-
metric scanning (LAS-5000; Fuji Film, Tokyo, Japan).
2.8. Immunohistochemistry
At 48 h after the last challenge, lungs were removed from the mice
after they were killed. Before the lungs were removed, the lungs and
trachea were ﬁlled intratracheally with a ﬁxative (4% formalin) using
a ligature around the trachea. Lung tissues were ﬁxed with 10% (v/v)
neutral buﬀered formalin. The specimens were dehydrated and embed-
ded in paraﬃn. For histological examination, 4 lm sections of ﬁxed
embedded tissues were cut on a Leica model 2165 rotary microtome
(Leica, Nussloch, Germany), placed on glass slides, deparaﬃnized,
and stained sequentially with hematoxylin 2 and eosin-Y (Richard-Al-
lan Scientiﬁc, Kalamazoo, MI). The inﬂammation score was graded by
three independent investigators who were not associated with this
study. The degree of peribronchial and perivascular inﬂammation
was evaluated on a subjective scale of 0–3, as described elsewhere. A
value of 0 was adjudged when no inﬂammation was detectable, a value
of 1 for occasional cuﬃng with inﬂammatory cells, a value of 2 for
most bronchi or vessels surrounded by a thin layer (one to ﬁve cells)
of inﬂammatory cells, and a value of 3 when most bronchi or vessels
were surrounded by a thick layer (more than ﬁve cells) of inﬂammatory
cells.
2.9. Determination of airway responsiveness to methacholine
Airway responsiveness was measured in mice 3 days after the last
challenge in an unrestrained conscious state, as described previously
[2–4]. Mice were placed in a barometric plethysmographic chamberthree times by 3% TDI dissolved in ethyl acetate/olive oil (1:4) at a 1-
s with 1% TDI dissolved in ethyl acetate/olive oil (1:4) by nebulization.
e same protocol but only with the solvent, ethyl acetate/olive oil (1:4).
rotected bottle from last sensitization to 2 days after ﬁrst challenge.
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averaged for 3 min. Aerosolized methacholine in increasing concentra-
tions (2.5–50 mg/ml, Sigma) were nebulized through an inlet of the
main chamber for 3 min. Readings were taken and averaged for
3 min after each nebulization. Enhanced pause (Penh), calculated as
(expiratory time/relaxation time  1) · (peak expiratory ﬂow/peak
inspiratory ﬂow), according to the manufacturers’ protocol, is a
dimensionless value that represents a function of the proportion of
maximal expiratory to maximal inspiratory box pressure signals and
a function of the timing of expiration. Penh was used as a measure
of airway responsiveness to methacholine. Results were expressed as
the percentage increase of Penh following doses of a concentration
of methacholine challenge with each concentration of methacholine,
where the baseline Penh (after saline challenge) was expressed as
100%. Penh values averaged for 3 min after each nebulization were
evaluated.
2.10. Statistics
Data are expressed as means ± S.D. Statistical comparisons were
performed by a 1-way analysis of variance, followed by the Fisher test.
Signiﬁcant diﬀerences between groups were determined by the un-
paired Student t test. Correlations were calculated by means of the
Spearman rank test. The statistical signiﬁcance was set at P < 0.05.3. Results
3.1. EGCG decreases the increased numbers of inﬂammatory
cells in BAL ﬂuids of TDI-sensitized and TDI-challenged
mice
The total cell numbers in BAL ﬂuids were signiﬁcantly in-
creased, about 3-fold, compared to those in the control group
2 days after the last TDI challenge. The number of neutrophils,Fig. 2. Eﬀect of EGCG on total and diﬀerential cellular components of BAL
with the vehicle (PBS), TDI plus EGCG (TDI + EGCG), and TDI (TDI), res
after the TDI challenge. The diﬀerent cell types were enumerated (A) and the
from one representative experiment out of 5 performed. This experiment use
NEU, neutrophil; EOS, eosinophil; LYM, lymphocyte; MAC, macrophageseosinophils, lymphocytes, and Macrophages in BAL ﬂuids was
increased 2.5-, 13.2-, 2-, and about 2-fold, respectively, com-
pared to those in the control group at 2 days after the TDI
challenge. Interestingly, the number of neutrophils, eosinoph-
ils, lymphocytes, and monocytes observed in BAL ﬂuids in
the EGCG-feeding group of mice decreased to the level of
1.6-, 1.9-, 2-, 1-fold of TDI-challenge group. The administra-
tion of the EGCG signiﬁcantly reduced the increase in neutro-
phils, eosinophils, lymphocytes, macrophages and total cells
elicited in the airway lumen 2 days after TDI inhalation
(Fig. 2).
3.2. EGCG inhibits ROS generation in BAL ﬂuids
Oxidative stress occurs in many allergic and immunologic
disorders. Number of studies have shown an increased produc-
tion of ROS in asthma, AR and AD, which contribute, in part,
to tissue injury at sites of inﬂammation [36]. Respiratory burst
of eosinophils activated by eotaxin has been demonstrated,
leading in ROS production [37,38]. We examined the eﬀect
of EGCG on ROS generation, as described in Fig. 3. For this
experiment, sampling was performed at 72 h after the last chal-
lenge. ROS generation in BAL ﬂuids was increased signiﬁ-
cantly at 72 h after TDI inhalation compared with the levels
after saline inhalation (Fig. 3). To investigate whether ROS
generation on EGCG aﬀects, we detected 3.3 lM 2 0,7 0-dichlo-
roﬂuorescein diacetate (DCFDA). When treated with EGCG,
ROS levels was lower (18.69 ± 0.7%) than for TDI-induced
levels of ROS (39.28 ± 0.8%), suggesting that the administra-
tion of EGCG had a reducing eﬀect on ROS generation.ﬂuids of TDI-sensitized and TDI-challenged mice. Mice were treated
pectively, as described in Section 2. The BAL cells were collected 2 days
numbers of each cellular component were counted (B). The results were
d 5mice (n = 5). #P < 0.05 vs. SAL + SAL, *P < 0.05 vs. OVA + SAL.
; TOT, total cell.
Fig. 3. Eﬀect of EGCG on ROS levels in BAL ﬂuids of TDI-sensitized and TDI-challenged mice. Sampling was performed at 72 h after the last
challenge in saline-inhaled mice administered saline (PBS), TDI-inhaled mice administered saline (TDI), and TDI-inhaled mice administered EGCG
(TDI + EGCG). The BAL ﬂuids were stained with PBS containing 3.3 lM DCFDA, and analyzed using ﬂow cytometry. ROS levels was lower
(18.69 ± 0.7%) than for TDI-induced levels of ROS (39.28 ± 0.8%), suggesting that the administration of EGCG had a reducing eﬀect on ROS
generation. The histogram shown are gated on BAL cells. Data represent means ± S.E.M. from 6 independent experiments.
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The results of histological examination of lung tissues paral-
leled the cell numbers in BAL ﬂuid. A marked inﬂux of inﬂam-
matory cells into the airway and around blood vessels, as well
as airway luminal narrowing by secreted mucus, was observed
in the TDI-sensitized group (Fig. 4). Administration of EGCG
resulted in a marked inhibition of cellular inﬁltration into the
airways and pulmonary blood vessels (Fig. 4).
3.4. EGCG reduces expression of MMP-9 mRNA and protein in
lung tissues and decreases TNF-a and IL-5 production in the
BAL ﬂuids of TDI-sensitized and TDI-challenged mice
The administration of EGCG signiﬁcantly reduced the in-
crease in expression of MMP-9 mRNA in the lung tissues
48 h after TDI inhalation (Fig. 5A). The administration of
EGCG also reduced the increase expression of MMP-9 protein
in lung tissues (Fig. 5B). Also the administration of EGCG sig-
niﬁcantly reduced the increased expression of MMP-9 gelatin-
olytic activity, as well as the level of pro-MMP-9 in lung
tissues 2 days after TDI inhalation (Fig. 5C). EGCG adminis-
tration also dramatically reduced the increase in TNF-a and
IL-5 production in BAL ﬂuids 48 h after TDI inhalation
(Fig. 6).
3.5. EGCG reduces AHR
Airway responsiveness was assessed as a percent increase of
Penh in response to increasing doses of methacholine. In TDI-
sensitized and TDI-challenged mice, the dose–response curve
of percent Penh shifted to the left compared with that of con-
trol mice (Fig. 7). In addition, the percent Penh produced by
methacholine administration (at doses from 2.5 to 50 mg/ml)
increased signiﬁcantly in the TDI-sensitized and TDI-
challenged mice compared with the controls. TDI-sensitized
and TDI-challenged mice treated with EGCG showed a dose–
response curve of percent Penh that shifted to the right
compared with that of untreated mice. The shift was dose-
dependent. These results indicate that EGCG treatment
reduces TDI-induced AHR.Fig. 4. EGCG inhibits lung inﬂammation. Mice were sensitized and
challenged as described in Section 2. Sections were obtained from the
lungs of mice receiving the vehicle (PBS), TDI (TDI), and TDI plus
EGCG (TDI + EGCG), respectively. Lungs were removed 2 days after
the last airway challenge. Sections were stained by haematoxylin and
eosin staining (100·).4. Discussion
This study is the ﬁrst to provide experimental evidence dem-
onstrating that EGCG inhibits TDI-induced airway inﬂamma-
tion in a murine model of asthma. EGCG profoundly inhibited
asthmatic reactions such as leukocytic recruitment into the air-
way and lung inﬂammation.Based on animal studies, the immunological processes in-
volved in airway inﬂammation of asthma are characterized
by the proliferation and activation of T cells of the subtype
Fig. 5. Eﬀects of EGCG administration on the expression of MMP-9 in the lungs of TDI-challenged mice. TDI-sensitized mice were pretreated (or
not) with EGCG before the TDI challenge. The cell extracts were prepared from the lungs of the experimental mice 48 h after challenge as well as
from the lung tissue of a naive control mouse. The extracts were subjected to RT-PCR for MMP-9 mRNA analysis (A) and densitometric analyses
were performed. Also, the extracts were subjected to immunoblot analysis with antibodies to MMP-9; the blots were reprobed with antibodies to b-
actin to conﬁrm the consistent application of samples (B), densitometric analyses were also performed. The eﬀect of EGCG on MMP production in
lung tissues of TDI-sensitized and TDI-challenged. Sampling was performed at 48 h after challenge with the PBS (lane 1), TDI (lane 2), or TDI plus
EGCG (lane 3) and analyzed by zymography. All of the groups of the experiment showed MMP-9 production, but the TDI plus EGCG group only
showed the active form of MMP-9 (C). Data represent means ± S.E.M. from 6 independent experiments. **P < 0.05 vs. OVA.
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eﬀector/proinﬂammatory cells with the release of mediators
and oxidants, which lead to the injury and inﬂammation noted
in asthma. ROS such as superoxide, hydrogen peroxide, and
possibly hydroxyl radicals contribute to inﬂammatory changes
in the asthmatic airway [36–39]. In support of this concept are
the high levels of ROS and oxidatively modiﬁed proteins in theairways of asthmatics [40,41,43,44]. High levels of ROS are
produced in the lungs of asthmatic patients by activated
inﬂammatory cells; i.e., eosinophils, alveolar macrophages,
and neutrophils.
Recently, EGCG and O-methylated derivatives of EGCG
(EGCG003Me) have been shown to suppress FceRI, a high-
aﬃnity IgE receptor that plays a key role in a series of acute
Fig. 6. The eﬀect of TNF-a and IL-5 on BAL ﬂuid cytokines. TDI-
sensitized mice were treated as described in Fig. 1. (A) Bronchoalveolar
lavage (BAL) was performed 4 h after the last airway challenge as
described by the manufacturer. TNF-a cytokine levels in the BAL
ﬂuids were measured by ELISA Kit. (B) The mice were bled 12 h after
the last airway TDI challenge. The detection limit of the IL-5 assay
was 5 pg/ml, and the assay is assured by the manufacturer to be speciﬁc
for the IL-5 ELISA kit. Data represent means ± S.E.M. from 5
independent experiments. #P < 0.05 vs. OVA.
Fig. 7. Eﬀect of EGCG on airway responsiveness in TDI-sensitized
and TDI-challenged mice. Airway responsiveness was measured at
72 h after the last challenge in saline-inhaled mice administered PBS
(PBS), ethyl acetate/olive oil-inhaled mice administered PBS (Vehicle),
TDI-inhaled mice administered saline (TDI) and TDI-inhaled mice
administered EGCG (TDI + EGCG). Airway responsiveness to aero-
solized methacholine was measured in unrestrained, conscious mice.
Mice were placed into the main chamber and were nebulized ﬁrst with
PBS, then with increasing doses (2.5–50 mg/ml) of methacholine for
3 min for each nebulization. Readings of breathing parameters were
taken for 3 min after each nebulization during which Penh values were
determined. Data represent means ± S.E.M. from 6 independent
experiments. *P < 0.05 vs. PBS, #P < 0.05 vs. OVA.
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chial asthma, allergic rhinitis, and food allergies expressed in
human basophilic KU812 cells [25]. It has also been reported
that EGCG suppresses IgE-mediated histamine release and leu-
kotriene C4 via the blockade of reactive oxygen synthesis [42].
In addition, EGCG has an inhibitory eﬀect on the gelatinolytic
activity of MMP-2 through enhancement of MMP-2 binding to
the tissue inhibitor of metalloproteinase-2 (TIMP-2) [29].
TDI-induced asthma has been recognized as a disease result-
ing from chronic airway inﬂammation characteristically asso-
ciated with the inﬁltration of lymphocytes, eosinophils, and
neutrophils into the bronchial lumen [6,7]. There is increasing
evidence that cytokine-inducible leukocyte-endothelial adhe-
sion molecules are important in the recruitment and migration
of leukocytes to the sites of inﬂammation [43,44]. Cell adhesion
molecules such as ICAM-1 and VCAM-1 are expressed on
endothelial cells and are markedly upregulated on the bron-
chial vascular endothelium of subjects with asthma [45,46].
Previous studies have demonstrated that the production of ma-
trix-degrading enzymes, such as MMP-9, is essential for leuko-
cytes extravasation and recruitment to the aﬀected sites [15,19].
Recently, it was demonstrated that the administration of an
MMP inhibitor reduces the migration of inﬂammatory cells
through the endothelial and epithelial basement membranes[28]. In addition, an MMP inhibitor regulates inﬂammatory
cell migration by reducing ICAM-1 and VCAM-1 expression
in a murine model of TDI-induced asthma [47].
In this murine model of asthma, we fed 0.3% EGCG into the
drinking water to evaluate the eﬀect of EGCGon the expression
ofMMP-9, TNF-a, and IL-5. It has been reported that EGCG is
better absorbed when administered through drinking ﬂuid than
intragastric (IG) administration, that most of the ingested
EGCG apparently does not get into the blood, that and the ab-
sorbed EGCG is preferentially excreted through the bile to the
colon [42]. It was also reported that tmax and Cmax were
85.5 min and 19.8 ng/ml, respectively, when EGCG was given
to rats intragastrically at a dose of 75 mg/kg.Our current EGCG
dose (169.2 mg/kg/day) was determined by extrapolating from
previous reports [48,49]. Prediction of the dosage requirement
for humans still requires accessible in vitro biological data and
other absorption estimates obtained from in vitro animal mod-
els. Therefore, further studies exploring in vitro/in vivo correla-
tion and inter-species scaling would provide a more accurate
estimation of concentrations/doses of EGCGand its eﬀect in hu-
mans. A better-designed clinical study is necessary to determine
the safety and eﬃcacy of EGCG in human asthmatic subjects.
In this study, EGCG reduced the expression of MMP-9 in
lung tissues of TDI-sensitized and TDI-challenged mice. These
eﬀects of EGCG may explain why the administration of
EGCG signiﬁcantly reduced the increase in neutrophils, eosin-
ophils, lymphocytes, macrophages, and the total cells elicited
in the airway lumen 2 days after TDI inhalation (Fig. 2). It
has long been postulated that the expression of MMP-9 is reg-
ulated by cytokines, especially TNF [50,51]. Our data demon-
strate that EGCG reduces the increased numbers of
inﬂammatory cells (the source of TNF- a) in the airways and
then decreases the increased levels of TNF-a in BAL ﬂuids
of TDI-sensitized and TDI-challenged mice (Fig. 6).
S.-H. Kim et al. / FEBS Letters 580 (2006) 1883–1890 1889Taken together, our results strongly indicate that EGCG re-
duces the pathologic lung damage due to the suppression of
ROS generation through the inhibition of inﬂammatory cells
migration by reducing MMP-9 expression and also by sup-
pressing TNF-a and IL-5 production. This study also supports
evidence that EGCG might oﬀer a new therapeutic approach
to allergic airway diseases.
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